The Lisle-based company raised $45 million a year ago in preparation for trials in Europe. It’s one of a handful of medical-device startups in Chicago that received significant funding.
If all goes well, Endotronix hopes to have its device in market in Europe either late next year or 2021 and in the U.S. the following year.
A new commercial investor, which the company did not identify, participated in the latest fundraising. Chicago investors include Joe Mansueto, founder of Morningstar, and energy entrepreneur Michael Polsky, said John Flavin, chief financial officer.